Burning Rock Biotech (BNR) Rises 14% on Strong Third Quarter Earnings

Author's Avatar
Dec 04, 2024

Burning Rock Biotech (BNR, Financial) saw its stock surge nearly 14% to $6.95. The company reported a revenue of 128.7 million RMB for the third quarter of 2024, marking a 1% increase year-over-year. After adjusting for Non-GAAP gross profit and Non-GAAP sales, general, and administrative expenses, the company achieved a profit of 25.2 million RMB for the quarter. This marks the third consecutive quarter of profitability for Burning Rock Biotech, with a consistent upward trend in earnings.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.